Pallasch, F.B.; Freytag, V.; Kriegs, M.; Gatzemeier, D.; Mair, T.; Voss, H.; Riecken, K.; Dawood, M.; Fehse, B.; Efferth, T.;
et al. The Histogenetic Origin of Malignant Cells Predicts Their Susceptibility towards Synthetic Lethality Utilizing the TK.007 System. Cancers 2024, 16, 2278.
https://doi.org/10.3390/cancers16122278
AMA Style
Pallasch FB, Freytag V, Kriegs M, Gatzemeier D, Mair T, Voss H, Riecken K, Dawood M, Fehse B, Efferth T,
et al. The Histogenetic Origin of Malignant Cells Predicts Their Susceptibility towards Synthetic Lethality Utilizing the TK.007 System. Cancers. 2024; 16(12):2278.
https://doi.org/10.3390/cancers16122278
Chicago/Turabian Style
Pallasch, Fabian Bernhard, Vera Freytag, Malte Kriegs, Dennis Gatzemeier, Thomas Mair, Hannah Voss, Kristoffer Riecken, Mona Dawood, Boris Fehse, Thomas Efferth,
and et al. 2024. "The Histogenetic Origin of Malignant Cells Predicts Their Susceptibility towards Synthetic Lethality Utilizing the TK.007 System" Cancers 16, no. 12: 2278.
https://doi.org/10.3390/cancers16122278
APA Style
Pallasch, F. B., Freytag, V., Kriegs, M., Gatzemeier, D., Mair, T., Voss, H., Riecken, K., Dawood, M., Fehse, B., Efferth, T., Schlüter, H., & Schumacher, U.
(2024). The Histogenetic Origin of Malignant Cells Predicts Their Susceptibility towards Synthetic Lethality Utilizing the TK.007 System. Cancers, 16(12), 2278.
https://doi.org/10.3390/cancers16122278
